An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Beh çet’s disease in long-term remission
ConclusionsAlthough no ocular attacks were observed for at least 1 year after IFX withdrawal, this prospective study indicates that IFX withdrawal should be considered carefully, even for patients in long term remission of ocular and extraocular lesions.
Source: Japanese Journal of Ophthalmology - Category: Opthalmology Source Type: research
More News: Angiography | Blindness | Japan Health | Opthalmology | Remicade | Restasis | Study | Vasculitis | Vitamin A